✦ LIBER ✦

Measurement of prostate specific antigen complexed to α1-antichymotrypsin to avoid unnecessary biopsy in patients with serum prostate specific antigen levels 4–20 ng/mL

✍ Scribed by YOJIRO NAKANO; KIKUO OKAMURA; SHINICHI TAKAMURA; NORIKO OKAMOTO; MASAHIRO NARISHIMA; YASUSHI YOSHINO; RYOHEI HATTORI; YOSHINARI ONO; SHINICHI OHSHIMA; TETSURO NAGASAKA

Book ID: 108976878
Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 171 KB
Volume: 12
Category: Article
ISSN: 0919-8172
DOI: 10.1111/j.1442-2042.2005.01167.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prostate specific antigen complexed to α

Prostate specific antigen complexed to α-1-antichymotrypsin in patients with intermediate prostate specific antigen levels

✍ Takashi Saika; Tomoyasu Tsushima; Yasutomo Nasu; Nobuyuki Kusaka; Yoshiyuki Miya 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 182 KB

Prostate-specific antigen (PSA) complexe

Prostate-specific antigen (PSA) complexed to α1-antichymotrypsin improves prostate cancer detection using total PSA in Japanese patients with total PSA levels of 2.0–4.0 ng/mL

✍ Takashi Kobayashi; Toshiyuki Kamoto; Koji Nishizawa; Kenji Mitsumori; Keiji Ogur 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 116 KB

Prostate specific antigen predominantly

Prostate specific antigen predominantly forms a complex with alpha1-antichymotrypsin in blood. Implications for procedures to measure prostate specific antigen in serum

✍ Hans Lilja; Abraham T. K. Cockett; Per-Anders Abrahamsson 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 471 KB 👁 2 views

Background. Prostate specific antigen (PSA) is a zymogen of a 33-kilodalton (kD) serine proteinase with extensive similarity to glandular kallikreins. The mechanism responsible for converting the zymogen into active proteinase has not been defined, but active PSA may be irreversibly inactivated in v

Does transrectal ultrasound guided eight

Does transrectal ultrasound guided eight-core prostate biopsy improve cancer detection rates in patients with prostate-specific antigen levels of 4.1–10 ng/mL?

✍ SHINYA YAMAMOTO; TAKAAKI ITO; TAKU AIZAWA; KENJIRO NODA; KIYOKAZU UMEZU; NORIHIK 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB

Transperineal ultrasound-guided 12-core

Transperineal ultrasound-guided 12-core systematic biopsy of the prostate for patients with a prostate-specific antigen level of 2.5–20 ng/ml in Japan

✍ Shinya Yamamoto; Ujin Kin; Kazuyoshi Nakamura; Masaaki Hamano; Yasuyo Nishikawa; 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 213 KB

Clinical features of patients who presen

Clinical features of patients who present with metastatic prostate carcinoma and serum prostate-specific antigen (PSA) levels < 10 ng/mL : The “PSA negative” patients

✍ Alison J. Birtle; Alex Freeman; John R. W. Masters; Heather A. Payne; Stephen J. 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 108 KB 👁 1 views

## Background: Although < 1% of men present with prostate-specific antigen (psa)-negative prostate carcinoma, in that they have serum psa levels much lower than the tumor burden would suggest, such patients represent a management dilemma. to the authors' knowledge, little information exists in the